Literature DB >> 20350292

Role of nuclear factor kappaB in liver health and disease.

Stuart M Robinson1, Derek A Mann.   

Abstract

NF-kappaB (nuclear factor kappaB) is a heterodimeric transcription factor that is constitutively expressed in all cell types and has a central role as a transcriptional regulator in response to cellular stress. In the present review, we discuss the role of NF-kappaB signalling in the maintenance of liver homoeostasis as well as in the pathogenesis of a wide variety of conditions affecting the liver, including viral hepatitis, steatohepatitis, cirrhosis and hepatocellular carcinoma. Much of the current knowledge of NF-kappaB signalling in the liver relates to the canonical pathway, the IKK [IkappaB (inhibitor of kappaB) kinase] complex and the RelA subunit. We explore the weaknesses of the experimental approaches to date and suggest that further work is needed to investigate in detail the discreet functions of each of the Rel subunits in liver physiology and disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20350292     DOI: 10.1042/CS20090549

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  24 in total

1.  Role and Regulation of p65/β-Catenin Association During Liver Injury and Regeneration: A "Complex" Relationship.

Authors:  Kari Nejak-Bowen; Akshata Moghe; Pamela Cornuet; Morgan Preziosi; Shanmugam Nagarajan; Satdarshan P Monga
Journal:  Gene Expr       Date:  2017-04-28

2.  CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.

Authors:  Guangzhi Chen; Renfan Xu; Shasha Zhang; Yinna Wang; Peihua Wang; Matthew L Edin; Darryl C Zeldin; Dao Wen Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-11-11       Impact factor: 4.310

3.  Influence of dietary taurine and housing density on oviduct function in laying hens.

Authors:  Bin Dai; Yuan-shu Zhang; Zi-li Ma; Liu-hai Zheng; Shuang-jie Li; Xin-hong Dou; Jian-sen Gong; Jin-feng Miao
Journal:  J Zhejiang Univ Sci B       Date:  2015-06       Impact factor: 3.066

4.  Fucosylated multiwalled carbon nanotubes for Kupffer cells targeting for the treatment of cytokine-induced liver damage.

Authors:  Richa Gupta; Neelesh Kumar Mehra; Narendra Kumar Jain
Journal:  Pharm Res       Date:  2013-09-17       Impact factor: 4.200

5.  N-acetylcysteine administration does not improve patient outcome after liver resection.

Authors:  Stuart M Robinson; Rehan Saif; Gourab Sen; Jeremy J French; Bryon C Jaques; Richard M Charnley; Derek M Manas; Steven A White
Journal:  HPB (Oxford)       Date:  2013-01-07       Impact factor: 3.647

Review 6.  Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target.

Authors:  Hua Wang; Fouad Lafdil; Xiaoni Kong; Bin Gao
Journal:  Int J Biol Sci       Date:  2011-04-27       Impact factor: 6.580

7.  Apoptosis Induction in Primary Human Colorectal Cancer Cell Lines and Retarded Tumor Growth in SCID Mice by Sulforaphane.

Authors:  Ming-Jenn Chen; Wei-Yu Tang; Che-Wei Hsu; Ya-Ting Tsai; June-Fu Wu; Chen-Wei Lin; Ya-Min Cheng; Yi-Chiang Hsu
Journal:  Evid Based Complement Alternat Med       Date:  2011-07-17       Impact factor: 2.629

8.  AGK enhances angiogenesis and inhibits apoptosis via activation of the NF-κB signaling pathway in hepatocellular carcinoma.

Authors:  Yanmei Cui; Chuyong Lin; Zhiqiang Wu; Aibin Liu; Xin Zhang; Jinrong Zhu; Geyan Wu; Jueheng Wu; Mengfeng Li; Jun Li; Libing Song
Journal:  Oncotarget       Date:  2014-12-15

9.  Employment of digital gene expression profiling to identify potential pathogenic and therapeutic targets of fulminant hepatic failure.

Authors:  En-Qiang Chen; Lang Bai; Dao-Yin Gong; Hong Tang
Journal:  J Transl Med       Date:  2015-01-27       Impact factor: 5.531

10.  Lutein decreases oxidative stress and inflammation in liver and eyes of guinea pigs fed a hypercholesterolemic diet.

Authors:  Jung Eun Kim; Richard M Clark; Youngki Park; Jiyoung Lee; Maria Luz Fernandez
Journal:  Nutr Res Pract       Date:  2012-04-30       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.